The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Neuromyelitis optica: Clinical predictors of a relapsing course and survival
Abstract
BACKGROUND: The relapsing form of neuromyelitis optica (NMO) is characterized by recurrent optic neuritis and myelitis, usually leading to severe, permanent, relapse-related neurologic impairment (e.g., blindness, paraplegia) within 5 years. Aggressive therapy aimed at relapse prevention initiated soon after disease onset may be expected to have a relatively greater impact on early relapse-related disability in NMO than in typical MS. Early prediction of a relapsing course and subsequent disease severity would facilitate design and implementation of clinical trials of such therapies. METHODS: A database of clinical and laboratory features of patients with NMO (n = 80) was used to develop potentially useful models predictive of a relapsing disease course and of subsequent disease severity as measured by survival. RESULTS: Predictors of a relapsing course were longer interattack interval between the first two clinical events (rate ratio [RR] = 2.16; per month increase), older age at onset (RR = 1.08; per year increase), female sex (RR = 10.0, female vs male), and less severe motor impairment with the sentinel myelitis event (RR = 0.48; per severity scale point increase). A history of other autoimmune disease (RR = 4.15; presence vs absence), higher attack frequency during the first 2 years of disease (RR = 1.21; per attack), and better motor recovery following the index myelitis event (RR = 1.84; per point increase) were associated with mortality due to relapsing NMO. CONCLUSIONS: These predictive models identify several clinical features, each available at diagnosis or early in the disease course, that predict relapsing disease and survival. These results may be useful to identify patients at high risk for severe, relapsing neuromyelitis optica in order to initiate early therapy for relapse prevention and to design clinical trials to study such interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
Self-citationA role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Plasma exchange for severe attacks of CNS demyelination: Predictors of response
Keegan, M., Pineda, A. A., McClelland, R. L., Darby, C. H., Rodriguez, M., & Weinshenker, B. G. (2002) · Neurology · doi:10.1212/wnl.58.1.143 · Cited by 600
Self-citationClinical, CSF, and MRI findings in Devic's neuromyelitis optica.
O'Riordan, J. I., Gallagher, H. L., Thompson, A. J., Howard, R. S., Kingsley, D. P., Thompson, E. J., McDonald, W. I., & Miller, D. H. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.4.382 · Cited by 397
Mandler, R. N., Ahmed, W., & Dencoff, J. E. (1998) · Neurology · doi:10.1212/wnl.51.4.1219 · Cited by 366
Devic's neuromyelitis optica: A clinicopathological study of 8 patients
Mandler, R. N., Davis, L. E., Jeffery, D. R., & Kornfeld, M. (1993) · Annals of Neurology · doi:10.1002/ana.410340211 · Cited by 335
Simón, I., Vendrell, J. J., Gutiérrez, C., Fernández‐Real, J. M., Vendrell, I., Gallart, L., Fontova, R., & Richart, C. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064490 · Cited by 103
Mandler, R. N., Dencoff, J. D., Midani, F., Ford, C. C., Ahmed, W., & Rosenberg, G. A. (2001) · Brain · doi:10.1093/brain/124.3.493 · Cited by 77
Neuromyelitis Optica With Unusual Vascular Changes
Lefkowitz, D., & Angelo, J. N. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050210105027 · Cited by 50
Cited by
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Self-citationThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Krupp, L. B., Banwell, B., & Tenembaum, S. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 755
EFNS guidelines on diagnosis and management of neuromyelitis optica
Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sorensen, P. S., & Hemmer, B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03066.x · Cited by 461
Metadata
- Authors
- Wingerchuk, D. M., & Weinshenker, B. G.
- Venue
- Neurology
- Published
- 2003-03-11
- Volume
- 60
- Issue
- 5
- Pages
- 848-853
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2079123351
- Cited by
- 331
- References
- 9
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuromyelitis optica: Clinical predictors of a relapsing course and survival. https://app.cochat.ai/papers/10.1212/01.wnl.0000049912.02954.2c
- The paper
- Wingerchuk, D. M., & Weinshenker, B. G. (2003). Neuromyelitis optica: Clinical predictors of a relapsing course and survival. Neurology. https://doi.org/10.1212/01.wnl.0000049912.02954.2c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.